Marco Ladetto, Prof
Dipartimento Medicina Traslazionale, Università del Piemonte Orientale - S.C. Ematologia ed Infrastruttura Ricerca Formazione ed Innovazione, A.O. SS. Antonio e Biagio e C. Arrigo (Alessandria, Italy) · Department of Translational Medicine of the Università degli Studi del Piemonte Orientale, Novara, Italy. AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy. · AO SS Antonio e Biagio e Cesare Arrigo, Alessandria
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marco Ladetto, Prof as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:47 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07453095 · Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell TherapyFondazione Italiana Linfomi - ETS · recruiting · Mantle Cell Lymphoma · study chair
- Ph2NCT06492837 · Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma PatientsFondazione Italiana Linfomi - ETS · active not recruiting · Follicular Lymphoma · principal investigator
- N/ANCT06008691 · A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical PracticeFondazione Italiana Linfomi - ETS · recruiting · Non-Hodgkin Lymphoma, B-cell · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.